Secondary wound closure with a new transparent negative-pressure dressing

The basic form of the TNPD (Fig. 1) is composed of the following materials:

Scissors are used to cut the OC to size. The dimensions depend on the size of the wound; the OC should overlap the wound surface by several centimeters in all directions. Cut an opening (P) of about 2 cm in diameter in the middle. The tubing connector to the negative-pressure pump is subsequently attached on top.

A TOF strip approximately 4–5 cm wide is cut to the appropriate length for the wound.

The protective film of the self-adhesive OC is removed so that the adhesive surface is exposed. The TOF strip is attached to the adhesive side so that the P is covered with the TOF. With this last step, the TNPD dressing assembly is complete and ready for use.

The TNPD is applied using the same technique as for a standard adhesive dressing (Fig. 2). The side of the dressing with the TOF strip is placed on the wound and fixed to the skin with the self-adhesive OC. Finally, a self-adhesive tubing connector (trackpad) from a negative-pressure pump unit (ACTIV.A.C., KCI USA, Inc., San Antonio, Texas, USA; continuous suction −125 mm Hg) is attached to the surface of the TNPD over the P. The negative pressure is directed to the wound through a tubing connector via the TNPD. The TOF strip applies suction to the full surface of the wound and the skin directly near the wound (compression). Secretions are continuously and actively drained (drainage).

A case study is used to present a new method of wound closure of a wound healing by secondary intention with the aid of a TNPD (Fig. 3, Video 1).

An obese 62-year-old female patient required an emergency median laparotomy with sigmoid resection due to perforated sigmoid diverticulitis. Postoperative complications included a subcutaneous infection of the laparotomy wound. The wound was fully opened except for the closed fascial suture. Negative-pressure therapy with a polyurethane foam and film occlusion was initiated. After 10 days and two dressing changes, the cavernous deep wound had a completely debrided and granulating surface.

A TNPD was used to continue negative-pressure therapy. Manual compression from a lateral orientation approximated the wound edges such that the cavernous wound opening was closed. The TNPD was then affixed and a self-adhesive trackpad provided a tubing connector to the negative-pressure pump. Before attaching the trackpad, a small polyurethane foam cube (V.A.C. Granufoam, KCI USA, Inc., San Antonio, Texas, USA; Suprasorb CNP Wound Foam, Lohmann & Rauscher International GmbH & Co. KG, Rengsdorf, Germany) was placed on the film opening to facilitate suction. A continuous negative pressure of −125 mm Hg was applied using a negative-pressure pump (ACTIV.A.C; KCI USA, Inc., San Antonio, Texas, USA).

By applying negative pressure, the TOF was drawn completely flat onto the skin and wound (compression). At the same time, wound secretions were continuously suctioned off (drainage). The transparency of the TNPD ensured that the entire wound could be completely observed at any time during therapy. It was not necessary to remove the dressing to assess the wound.

The first dressing change took place on the third day. The superficial TNPD was removed painlessly. What had previously been a gaping wound was now fully adapted with no clinical signs of infection. Small regular suction dimples were seen where the wound surface and skin had been in suction contact with the TOF.

Negative-pressure therapy was continued for another 4 days. To this end, a new TNPD was affixed and connected to the negative pressure generator using the technique described. After a total treatment duration of 7 days, cutaneous negative-pressure therapy was stopped. The TNPD was definitively removed. The small suction dimples were again visible on the skin where it had come into contact with the TOF. The wound was non-irritating and exhibited stable adaptation across its entire length. A conventional wet dressing was applied. When the wound was examined the following day, suction changes were no longer visible. The fully documented course of treatment is shown in the video.

The TNPD is a new type of transparent occlusive dressing to which negative pressure can be applied.

The wound dressing described here consists of an open-pore double-layer drainage film (TOF). The TOF was originally developed for intra-abdominal negative-pressure therapy [4, 5]. The drainage film consists of two transparent membranes that have innumerable perforations that are uniformly arranged and evenly spaced. There is a space between the two membranes that does not collapse when suction is applied. Fluids and gases can be drained through the pores and within the interstitial space. The absorption area is very large compared to the volume of material used. The negative pressure is generated over the entire surface of the drainage film.

Unlike polyurethane foam, the open-pore drainage material of the TOF can be applied intra-abdominally, in direct contact with peritoneal organs. Recently, our group was able to show that the TOF can also be used for intrathoracic negative-pressure therapy in pleural empyema [6].

The adhesion of the TOF to tissue is not as pronounced as with polyurethane foams. It is known from endoscopic application that adhesion of foam drainage to a granulating wound surface can be so strong that the removal procedure can result in tearing of the sponge and even of the drainage tubes [7, 8]. For some years now, we have been using the TOF in endoscopic negative-pressure therapy to produce special thin-lumen film drains, which have considerably expanded the spectrum of endoscopic therapy [9‐11]. These film drains are always easy to remove. We have not yet observed any tears in film material in a wide range of applications.

As an open-pore drainage material, the TOF can also be used to provide negative-pressure therapy for wounds on the surface of the body. Because the dressing is less adherent to the tissue surface, it is virtually painless to remove during dressing changes. The debriding properties are less pronounced than those of a polyurethane foam. Also, these observations are already known to us from numerous applications in endoscopic negative-pressure therapy.

With the TNPD assembly shown, the TOF can be used for all types of skin wounds where cutaneous negative-pressure therapy is indicated. The TNPD can also be used to continue and complement negative-pressure therapy with polyurethane foams, in combination with polyurethane foams and together with abdominal negative-pressure therapy. There is a wide range of possible applications. The dressing is easy to handle and to prepare.

In negative-pressure therapy, the available materials must always be used creatively. The size and proportions of the drainage material must be adjusted. The TNPD has been developed from clinical application. Together with industry partners, solutions must be found to provide users with standardized and approved medical devices that also meet the formal requirements for the safety of medical devices.

The video shows a case study demonstrating how the TNPD can be used as an alternative method of wound closure for a wound healing by secondary intention. This was preceded by negative-pressure therapy with polyurethane foams. The major advantage of the TNPD is that it does not require surgical closure with sutures. This innovation in the use of negative-pressure therapy is described here for the first time.

No complications were observed during cutaneous therapy. It is conceivable that infection of the closed subcutaneous tissue may occur, as is the case with surgical wound closure. This would require reopening of the wound and expansion of local treatment. As with any open-pore drainage material, the pores of the TOF can become clogged, rendering the TNPD non-functional. Leakage of the dressing also leads to non-functionality, as negative pressure is no longer exerted on the wound. Both of these potential faults can easily be checked by inspecting the dressing visually or by means of a leakage alarm on the negative-pressure pump, and can be rectified with a dressing change. However, it is arguably a disadvantage to continue negative-pressure therapy whereby the patient is “tethered” to a dressing assembly that involves a drainage tube and pump, as this could lead to prolonged immobility. By contrast, practical clinical experience from numerous applications since 2017 has shown that patient mobility is minimally restricted by a TNPD and acceptance of the dressing is very high. One possibility is the use of smaller pumps that increase mobility and patient comfort. Similarly, it is conceivable that treatment could be continued in an outpatient setting after initial application. This would reduce inpatient treatment times and free up surgical capacity that would otherwise be taken up by surgical wound closure using sutures.

The key advantage of the TNPD over all other cutaneous negative-pressure dressings is its transparency. The wound surface and environment can be inspected visually at any time while simultaneously applying negative pressure, and without the need to remove the dressing.

Transparent negative-pressure dressing is a new type of see-through wound dressing to which negative pressure can be applied. Thanks to its transparency, the wound can be fully inspected visually during treatment. The dressing is suitable for cutaneous wounds where negative-pressure therapy may be used. The dressing assembly can be used to achieve secondary wound closure.